{"text_format":"1","workbook":"xlsx","n_sheets":1,"sheets":["CF_E"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"CF_E","index":0,"n_rows":48,"n_cols":4,"rows_kept":48,"cut":false,"hidden":false,"merged":[[2,1,2,2]]}
[]
[null,"Consolidated statement of cash flows (IFRS)"]
[null,"from 1 October 2021 to 30 September 2022"]
[null,null,"2021/22\n1 Oct 21 to 30 Sep 22","2020/21\n1 Oct 20 to 30 Sep 21"]
[null,null,"€ k","€ k"]
[null,"Consolidated profit",295911,237519]
[null,"Income taxes",107578,101531]
[null,"Interest income/expenses",-3657,7803]
[null,"Result from other investments",-87,-95]
[null,"Result from the change in fair value of contingent purchase price obligations",-53746,1840]
[null,"Result from the sale of asstes held for sale",0,-2447]
[null,"Depreciation and amortization",69769,61584]
[null,"Gains/losses on disposal/depreciation of fixed assets",259,1442]
[null,"Interest and dividens received",1733,1376]
[null,"Interest paid",-1520,-1629]
[null,"Income tax payments",-120444,-97908]
[null,"Trade receivables",-74370,-62102]
[null,"Inventories",-74631,18]
[null,"Other assets",-38273,-5531]
[null,"Trade payables",33729,52692]
[null,"Provisions and financial liabilities",39273,54459]
[null,"Other liabilities",4762,12111]
[null,"Cashflow from operating activities",188199,362663]
[]
[null,"Cash outflow for investments in property, plant and equipment",-42804,-30122]
[null,"Cash outflow for investments in other intangible assets",-39167,-35979]
[null,"Proceeds from disposal of fixed assets",218,403]
[null,"Proceeds from disposal of financial assets",0,0]
[null,"Cash outflow for investments in financial assets",-5851,-2416]
[null,"Purchase of shares in affiliated consolidated companies, net of cash acquired",-61290,-11509]
[null,"Proceeds from the sale of assets held for sale",0,4423]
[null,"Cashflow from investing activities",-148894,-75200]
[]
[null,"Change in current loans",-597,420]
[null,"Change in treasury receivables",56008,-241624]
[null,"Change in treasury payables",11671,14950]
[null,"Cash receipts from sale-and-leaseback transactions",0,3977]
[null,"Repayment of leasing liabilities",-19904,-17727]
[null,"Dividend payment to shareholders of Carl Zeiss Meditec AG",-80497,-44720]
[null,"Dividend payment to non-controlling interests",-3461,-1165]
[null,"Cashflow from financing activities",-38236,-285889]
[]
[null,"Effect of exchange rate fluctuation on cash and cash equivalents",-779,-337]
[null,"Change in cash and cash equivalents",290,1237]
[null,"Cash and cash equivalents, beginning of reporting period",7439,6202]
[null,"Cash and cash equivalents, end of reporting period",7729,7439]
[]
[null,"The following notes are an integral part of the audited consolidated financial statements."]